Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content +++ Key Features +++ Essentials of Diagnosis ++ Severe progressive pneumonia in a child with compromised immunity Diarrhea and neurologic signs are common Direct fluorescent antibody staining of respiratory secretions and urinary antigen tests are highly specific but do not identify all infections +++ General Considerations ++ Legionella pneumophila causes two distinct clinical syndromes: Legionnaires disease and Pontiac fever Contaminated cooling towers and heat exchangers have been implicated in several large institutional outbreaks Person-to-person transmission has not been documented Few cases of Legionnaires disease have been reported in children; most were in children with compromised cellular immunity +++ Clinical Findings +++ Symptoms and Signs ++ Legionnaires disease Abrupt onset of fever, chills, anorexia, and headache Pulmonary symptoms appear within 2–3 days and progress rapidly Cough is nonproductive early Purulent sputum occurs late Hemoptysis, diarrhea, and neurologic signs (including lethargy, irritability, tremors, and delirium) are seen Pontiac fever is a milder, self-limited illness without evidence of pneumonia +++ Differential Diagnosis ++ Other bacterial pneumonias Viral pneumonias Mycoplasma pneumonia Fungal disease +++ Diagnosis +++ Laboratory Findings ++ WBC count is usually elevated in Legionnaires disease Cultures from sputum, tracheal aspirates, or bronchoscopic specimens, when grown on specialized media are positive in 70–80% of patients at 3–5 days of culture Direct fluorescent antibody staining of sputum or other respiratory specimens is only 50–70% sensitive but 95% specific PCR detection of respiratory secretions for Legionella is available at some centers Urine antigen tests for Legionella antigen are highly specific, but only detect L pneumophila serotype 1, which is the most common community-acquired L pneumophila infection +++ Imaging ++ Chest radiographs Show rapidly progressive patchy consolidation Cavitation and large pleural effusions are uncommon +++ Treatment ++ Intravenous azithromycin, 10 mg/kg/d given as a once-daily dose (maximum dose 500 mg), is the drug of choice in most children In immunocompromised patients, levofloxacin is recommended (not approved for this indication in children < 18 years of age) because fluoroquinolones are bactericidal agents. Doxycycline (not recommended for children < 8 years of age unless benefit exceeds risk) and TMP-SMX are alternative agents Duration of therapy is 5–10 days if azithromycin is used; for other antibiotics a 14- to 21-day course Oral therapy may be substituted for intravenous therapy as the patient's condition improves +++ Outcome +++ Complications ++ Hematogenous dissemination may result in extrapulmonary foci of infection, including pericardium, myocardium, and kidneys Legionella may be the cause of culture-negative endocarditis +++ Prevention ++ No vaccine is available Legionella is naturally found in water, so ensuring proper disinfectant and water temperature maintenance of water supplies helps prevent cases Good ... Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.